Name Address/P.O. Box Postal Code/City Country Contact Person Telephone Email Website Number of Employees Founded (year) Type of Laboratory
Areas of Activity
›
› › › › › › › › › ›
›
FyoniBio GmbH Robert-Rössle-Str. 10 13125 Berlin Germany Dr Doreen Weigelt +49-30-9489-2500 contact@fyonibio.com www.fyonibio.com 20+ 2019 ISO 9001 certified and GCLP compliant S1 and Bio2 Service business with own technology platform in cell line development, USP/ DSP development, MS-based PTM & glycoanalytics, bioassays and clinical bioanalysis under GCLP
As spin-out from Glycotope we are a contract development organisation offering our 20 years of experience in developing biopharmaceuticals from cell line development to clinical bioanalysis and bioassays for our customers. We are an ISO 9001 certified company located on the biotech campus Berlin Buch and operate in part under GCLP. We provide: › One-stop shop from clone development to RCB for CHO and GlycoExpress® cell lines › Process development ready to transfer to the GMP facility of your choice › Cutting edge know-how in glycobiology (analytics and cell biology) › Bioassay development for a wide range of proteins › Excellent know-how in PK, biomarker, and immunogenicity analysis of clinical samples under good clinical and laboratory practice (GCLP) › Excellent track record: Delivering high quality in service and products › Professional project management and customer care › Experienced team
Glycosylation and cell line development Gycosylation is dependent on the host cell line. FyoniBio provides cell line development services using its human GlycoExpress® (GEX®) cell lines as well as its CHO platform technology CHOnamite®.
Process development We offer upstream, downstream, formulation, and analytical development. Our upstream process development is based on mammalian cell culture systems (GlycoExpress®, CHO-K1, CHO-DG44, and others) for fed-batch, perfusion, and intensified fed-batch processes.
